Drugs and devices synergy: optimal DAPT & switching strategies - Round Table Webinar

In this special webinar about drugs and device synergy Thomas Cuisset leads the discussion with Adrian Banning and Olivier Varenne in order to shade light on the many new treatment options made possible by new drugs available on the market. Starting with the statement that the lesions and patients are getting more complex, understand how to optimally use dual antiplatelet therapy (DAPT) in high-risk acute coronary syndrome (ACS) patients and patients with chronic NOAC undergoing complex PCI. Learn also more about switching strategies for P2Y12 blockers after ACS.

This PCR Webinar is supported by Boston Scientific in the form of an educational grant.
The Scientific Programme has not been influenced by its sponsor